Cite
HARVARD Citation
Yang, H. et al. (2017). Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer. Scientific reports. 7 (1), pp. 1-8. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yang, H. et al. (2017). Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer. Scientific reports. 7 (1), pp. 1-8. [Online].